A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.